Clinical trials
Recruiting Observational Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Azienda USL Reggio Emilia - IRCCS | 1 |
| Cancer Support Community, Research and Training Institute, Philadelphia | 1 |
| Carmen Fava | 1 |
| Center for International Blood and Marrow Transplant Research | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Hikma Pharmaceuticals LLC | 1 |
| M.D. Anderson Cancer Center | 1 |
| National Taiwan University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 22 |
| Leukemia, Myeloid, Acute | 6 |
| Hematologic Neoplasms | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Hodgkin Disease | 3 |
| Leukemia | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Myelodysplastic Syndromes | 3 |
| Anemia, Aplastic | 2 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.